<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39400814</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-2598</ISSN><JournalIssue CitedMedium="Print"><Volume>1463</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Advances in experimental medicine and biology</Title><ISOAbbreviation>Adv Exp Med Biol</ISOAbbreviation></Journal><ArticleTitle>Comparison of Eye-Tracking Parameters and Brain Oxygen Saturation in Patients with COVID-19 Moderate Pneumonia.</ArticleTitle><Pagination><StartPage>141</StartPage><EndPage>145</EndPage><MedlinePgn>141-145</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-3-031-67458-7_24</ELocationID><Abstract><AbstractText Label="UNLABELLED">The aim was to study the relationship between eye tracking (ET) parameters and cerebral tissue oxygen saturation (SctO<sub>2</sub>) values in the acute period of moderate COVID-19 pneumonia.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A single-centre, non-randomised study included 92 patients in the acute period of SARS-CoV-2 moderate pneumonia (Delta variant). The mean time from admission was 1.5 ± 0.9 days. M:49, W:43. The mean age was 34.7 ± 3.9 years. The eye vergence reactivity index (VRx) was determined using a mobile ET. The cerebral oximetry was performed using Fore-Sight 2030 and included the detection of the SctO<sub>2</sub> level in the frontal lobe (FLP) region. Statistical analysis was carried out using the methods of parametric statistics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The calculated vertical VRx was 0.781 ± 0.118. The calculated horizontal VRx was 0.821 ± 0.107. SctO<sub>2</sub> in the FLP varied within the range from 61% to 73%. The average SctO2 values were 65.4 ± 5.2% over the left FLP and 66.2 ± 6.3% over the right FLP (p = 0.872). The regression analysis showed that HVRx and VVRx were correlated with SctO<sub>2</sub> levels in both FLPs (p = 0.035 and p = 0.034, respectively, and p = 0.040 and p = 0.049, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cerebral oxygen saturation in moderate pneumonia caused by the SARS-CoV-2 coronavirus has a significant destabilising effect on the oculomotor synergy (VVRx and HVRx) (p &lt; 0.05).</AbstractText><CopyrightInformation>© 2024. Oxygen Transport to Tissue International.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trofimov</LastName><ForeName>Alex O</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarkova</LastName><ForeName>Darya I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Department of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trofimova</LastName><ForeName>Kseniia A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemoto</LastName><ForeName>Edwin M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of New Mexico School of Medicine, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bragina</LastName><ForeName>Olga A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Lovelace Biomedical Research Institute, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bragin</LastName><ForeName>Denis E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of New Mexico School of Medicine, Albuquerque, NM, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lovelace Biomedical Research Institute, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medvedeva</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalinkina</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurological Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Exp Med Biol</MedlineTA><NlmUniqueID>0121103</NlmUniqueID><ISSNLinking>0065-2598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089382" MajorTopicYN="Y">Oxygen Saturation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010092" MajorTopicYN="Y">Oximetry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005133" MajorTopicYN="N">Eye Movements</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pneumonia</Keyword><Keyword MajorTopicYN="N">Cerebral oxygenation</Keyword><Keyword MajorTopicYN="N">Eye tracking</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39400814</ArticleId><ArticleId IdType="doi">10.1007/978-3-031-67458-7_24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Henneghan AM, Lewis KA (2022) Gill E cognitive impairment in non-critical, mild-to-moderate COVID-19 survivors. Front Psychol 13:770459. https://doi.org/10.3389/fpsyg.2022.770459</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2022.770459</ArticleId><ArticleId IdType="pubmed">35250714</ArticleId><ArticleId IdType="pmc">8891805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immunity 87:18–22. https://doi.org/10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Aidar MN, Gomes TM (2021) de Almeida MZH low visual acuity due to acute macular neuroretinopathy associated with COVID-19: a case report. Am J Case Rep 22:e931169. https://doi.org/10.12659/AJCR.931169</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.931169</ArticleId><ArticleId IdType="pubmed">33930011</ArticleId><ArticleId IdType="pmc">8097744</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurttaser Ocak S, Ozturan SG, Bas E (2022) Pupil responses in patients with COVID-19. Int Ophthalmol 42:385–391. https://doi.org/10.1007/s10792-021-02053-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-02053-z</ArticleId><ArticleId IdType="pubmed">34613562</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirgen G et al (2022) Abnormal quantitative pupillary light responses following COVID-19. Int Ophthalmol 42:2847. https://doi.org/10.1007/s10792-022-02275-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-022-02275-9</ArticleId><ArticleId IdType="pubmed">35380318</ArticleId><ArticleId IdType="pmc">8980787</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucha A, Collins M, Elbin R et al (2014) A brief vestibular/ocular motor screening (VOMS) assessment to evaluate concussions. Am J Sports Med 42(10):2479–2486. https://doi.org/10.1177/0363546514543775</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0363546514543775</ArticleId><ArticleId IdType="pubmed">25106780</ArticleId><ArticleId IdType="pmc">4209316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly K, Anghinah R, Kullmann A et al (2022) Oculomotor, vestibular, reaction time, and cognitive tests as objective measures of neural deficits in patients post COVID-19 infection. Front Neurol 13:919596. https://doi.org/10.3389/fneur.2022.919596</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.919596</ArticleId><ArticleId IdType="pubmed">36188407</ArticleId><ArticleId IdType="pmc">9516636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff TC, Mohareb AM, Giri J et al (2020) Thrombosis in COVID-19. Am Hematol 95:1578–1589. https://doi.org/10.1002/ajh.25982</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K, Jaki Mekjavic P, Vidovic Valentincic N et al (2021) An update on COVID-19 related ophthalmic manifestations. Ocul Immunol Inflamm 29:684–689. https://doi.org/10.1080/09273948.2021.1896008</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2021.1896008</ArticleId><ArticleId IdType="pubmed">33826465</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ (2021) Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci 12:573–580. https://doi.org/10.1021/acschemneuro.0c00793</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Okutin O, Okutin G (2011) Evaluation and leveling eye-tracker «noise». Exp Psychol 4:100–105. (In Russian)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>